Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham e-Theses
You are in:

BIOCHEMICAL CHARACTERISATION OF PIMELATE BIOSYNTHETIC GENES OF Mycobacterium tuberculosis

GUGU, MUSA,FILIBUS (2019) BIOCHEMICAL CHARACTERISATION OF PIMELATE BIOSYNTHETIC GENES OF Mycobacterium tuberculosis. Doctoral thesis, Durham University.

Full text not available from this repository.
Author-imposed embargo until 14 June 2022.

Abstract

Emergence of drug resistant tuberculosis (TB) and comorbidity with HIV, especially in the sub-Saharan Africa and Asia, has exacerbated the problem of TB, with an estimated 1.6 million people dying of the disease worldwide in 2017 alone. This programme of work approached the problem of TB by utilising a two-pronged approach to novel drug identification.
The first approach investigated enzymes involved in pimelate biosynthesis in Mycobacterium tuberculosis (Mtb). Pimelate, the precursor of biotin synthesis in bacteria, is an essential micronutrient needed for the survival of the organism. This biochemical study identified four enzymes, Rv0089, Rv1882c, Rv3177 and Rv2715 as possible proteins involved in this pathway. Due to ongoing issues with toxicity in various expression hosts, only Rv0089 was purified and biochemical studies performed. These studies confirmed the enzyme to be a methyl transferase capable of converting S-adenosyl-methionine (SAM) into S-adenosyl-L-homocysteine (SAH) with a preference for malonyl-CoA.
The second approach analysed isoxyl and SQ109 hybrid anti-tubercular agents. A series of hybrids were synthesized to develop a potential new lead compound with multiple modes of action and decreased propensity to develop resistance. A lead compound with an MIC of 0.120 µg/mL against Mtb was successfully synthesised showing markedly higher activities than the parental drugs (SQ109 MIC = 0.48 µg/mL and isoxyl MIC = 0.24 µg/mL). Additionally, this compound was equally potent against rifampicin and isoniazid singularly resistant Mtb.
This work has therefore provided a basis by which new anti-tubercular drugs can be developed.

Item Type:Thesis (Doctoral)
Award:Doctor of Philosophy
Keywords:Mycobacterium tuberculosis Biotin Pimelate Characterisation
Faculty and Department:Faculty of Social Sciences and Health > Medicine and Health, School of
Thesis Date:2019
Copyright:Copyright of this thesis is held by the author
Deposited On:17 Jun 2019 08:02

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitter